Can a culturally tailored program help hispanics beat fatty liver disease?
NCT ID NCT07199491
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a lifestyle program called Healthy Liver/Hígado Sano for Hispanic patients with metabolic-dysfunction associated steatotic liver disease (MASLD), also known as fatty liver disease. The program includes education sessions and family support to help participants lose weight and improve liver health. Researchers will check if the program is practical and liked by patients, with 64 adults expected to join.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Weight-Loss surgery beat drugs for advanced liver damage?
- Navy beans take on fatty liver: a diet swap put to the test
- New drug miricorilant tested for fatty liver disease safety
- Natural compound SAMe tested to block liver cancer in High-Risk patients
- New drug combo targets genetic fatty liver in Mid-Stage trial
- Fatty liver study tracks 922 patients to uncover hidden risks